Document is current

Any future updates will be listed below

Preclinical assessment of pharmacokinetics and anticonvulsant activity of CBDTech, a novel orally administered cannabidiol (CBD) formulation for seizure and epilepsy

Crossref DOI link: https://doi.org/10.1186/s42238-025-00322-7

Published Online: 2025-09-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark